We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.71B
1-Year Est. Return
65.19%
This Fund
S&P 500
This Quarter
Est. Return
-5.87%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.11B
AUM Growth
-$636M
(-17%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-11.42%
Top 10 Holdings %
Top 10 Hldgs %
18.55%
Holding
435
New
67
Increased
62
Reduced
121
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$28.9M |
| 2 |
CVS Health
CVS
|
+$27.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$25M |
| 4 |
UnitedHealth
UNH
|
+$20.4M |
| 5 |
Salesforce
CRM
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$43.8M |
| 2 |
iShares MSCI Japan ETF
EWJ
|
+$42.6M |
| 3 |
Coca-Cola
KO
|
+$40M |
| 4 |
Illumina
ILMN
|
+$31.6M |
| 5 |
Hain Celestial
HAIN
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.74% |
| 2 | Technology | 17.53% |
| 3 | Consumer Discretionary | 16.73% |
| 4 | Industrials | 11.77% |
| 5 | Energy | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Toll Brothers
TOL
$12.4B
| $3.81M | 0.12% |
111,200
| – | – |
|
202
HF Sinclair
DINO
$20B
| $3.79M | 0.12% |
+77,500
| New | +$3.69M |
|
203
Darden Restaurants
DRI
$23.9B
| $3.73M | 0.12% |
60,829
-3,244
| -5% | -$206K |
|
204
ENI
E
$80.1B
| $3.69M | 0.12% |
117,500
| – | – |
|
|
HAR
205
DELISTED
Harman International Industries
HAR
| $3.64M | 0.12% |
37,875
-1,300
| -3% | -$136K |
|
206
Travere Therapeutics
TVTX
$5.95B
| $3.61M | 0.12% |
178,034
-65,616
| -27% | -$1.94M |
|
207
EQT Corp
EQT
$31.9B
| $3.58M | 0.12% |
+101,586
| New | +$4.14M |
|
208
PNC Financial Services
PNC
$94.5B
| $3.57M | 0.11% |
+40,000
| New | +$3.76M |
|
209
JetBlue
JBLU
$1.65B
| $3.53M | 0.11% |
136,826
-342,890
| -71% | -$8.08M |
|
|
ENDP
210
DELISTED
Endo International plc
ENDP
| $3.52M | 0.11% |
50,850
-3,200
| -6% | -$256K |
|
211
Carlisle Companies
CSL
$12.9B
| $3.52M | 0.11% |
40,275
-1,500
| -4% | -$150K |
|
212
iShares S&P India Nifty 50 Index Fund
INDY
$532M
| $3.48M | 0.11% |
124,800
| – | – |
|
|
HDS
213
DELISTED
HD Supply Holdings, Inc.
HDS
| $3.48M | 0.11% |
+121,420
| New | +$4.07M |
|
214
Fortinet
FTNT
$127B
| $3.46M | 0.11% |
407,625
-14,000
| -3% | -$124K |
|
|
SNP
215
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $3.45M | 0.11% |
56,010
| – | – |
|
|
PDCE
216
DELISTED
PDC Energy, Inc.
PDCE
| $3.45M | 0.11% |
+65,000
| New | +$3.33M |
|
217
Repligen
RGEN
$9.84B
| $3.44M | 0.11% |
123,690
+37,465
| +43% | +$1.35M |
|
218
Bank of America
BAC
$408B
| $3.43M | 0.11% |
+220,000
| New | +$3.7M |
|
219
Lear
LEA
$6.34B
| $3.36M | 0.11% |
30,875
-12,925
| -30% | -$1.35M |
|
|
TSS
220
DELISTED
Total System Services, Inc.
TSS
| $3.35M | 0.11% |
+73,825
| New | +$3.36M |
|
221
Equinor
EQNR
$106B
| $3.29M | 0.11% |
225,600
| – | – |
|
222
Vertex Pharmaceuticals
VRTX
$130B
| $3.21M | 0.1% |
30,830
| – | – |
|
223
Hasbro
HAS
$12.8B
| $3.16M | 0.1% |
43,775
-1,500
| -3% | -$116K |
|
224
Crown Holdings
CCK
$12.3B
| $3.16M | 0.1% |
68,975
-2,400
| -3% | -$121K |
|
225
DexCom
DXCM
$33.4B
| $3.13M | 0.1% |
+145,720
| New | +$3.25M |
|
Similar funds
MSC
BC
FEG
HCM
OH
BCM
CCI
MCM
Castleark Management's Q3 2015 Portfolio in Review
As of Q3 2015, Castleark Management held 435 positions worth $3.11B, down 17% from $3.74B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Castleark Management withdrew a net $355M in Q3 2015, closing 71 positions and reducing 121 holdings. Its most notable exit was Aptiv, an estimated $43.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in Bristol-Myers Squibb worth $23.3M.
- Castleark Management's largest Q3 2015 buy was Bristol-Myers Squibb: 393,310 shares worth $23.3M.
- Castleark Management added most to Ulta Beauty in Q3 2015, an estimated $28.9M increase.
- Castleark Management's biggest Q3 2015 reduction was iShares MSCI Japan ETF, cutting an estimated $42.6M.
- Castleark Management fully exited Aptiv in Q3 2015, selling an estimated $43.8M.
- Castleark Management's ten largest holdings make up 19% of its $3.11B portfolio in Q3 2015.
- Castleark Management opened 67 new positions and closed 71 in Q3 2015.
- Castleark Management's portfolio value fell 17% quarter-over-quarter to $3.11B.
Based on Castleark Management's 13F filing for Q3 2015, filed 17 Nov 2015.